Human recombinant BCMA (from HEK293)
- Coniugazione:Non coniugato
- Protein/peptide type:Recombinant
- Sorgente luminosa:HEK293 cells
- Specie:Human
- Condizioni di conservazione:–20 °C
- Contenuto di endotossine:Less than 0,01 EU per μg by the LAL method.
- Attività biologica:Lyophilised from 0,22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 150 mM NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation. Measured by its binding ability in a functional ELISA. Immobilised Human BAFF, His Tag (Cat. No. BAF-H5248) at 5 μg/ml (100 μl/well) can bind Human BCMA, Llama IgG2b Fc Tag (Cat. No. BCA-H5259) with a linear range of 0,02 - 0,4 ng/ml (QC tested). Measured by its binding ability in a functional ELISA. Immobilised Human BCMA, Llama IgG2b Fc Tag (Cat. No. BCA-H5259) at 2 μg/ml (100 μl/well) can bind Anti-Human BCMA Mab with a linear range of 0,4 - 3 ng/ml (Routinely tested).
- ID gene:Q02223-1
- Senza corriere:Y
- Protease-free:Y
- Senza animali:Y
- Protein synonyms:CD269|TNFRSF17|BCM
- Protein/peptide name:BCMA
- Purezza:>90%
- Peso molecolare:33,7 kDa
- Livello di endotossine:Low
- Formulazione:Lyophilised from 0,22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 150 mM NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation.
- Esente da nucleasi:Y
- Temperatura di spedizione:Powder, RT
Frequently Bought Together